Tumor necrosis factor‐α in combination with interferon‐γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Ding, A. H., Nathan, C., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,840

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

Kindler, V., Sappino, A., Grau, G. E., Piguet, P., & VASSALLI, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,239

ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE

Waage, A., Halstensen, A. I., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,085

Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon

Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 876

Tumour necrosis factors α and β inhibit virus replication and synergize with interferons

Wong, G. H., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 707

Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor

Munker, R., Gasson, J. C., Ogawa, M., & Koeffler, H. P. (1986) · Nature · doi:10.1038/323079a0 · Cited by 500

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Murray, H. W., Rubin, B. Y., & Rothermel, C. D. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111107 · Cited by 403

Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Bermudez, L. E., & Young, L. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.3006 · Cited by 379

Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function

Locksley, R. M., & Scott, P. (1991) · Parasitology Today · doi:10.1016/0169-4758(91)90034-l · Cited by 27

Insulin‐like Growth Factor (IGF)‐I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis

Gomes, C. M. D. C., Goto, H., da Matta, V. L. R., Laurenti, M. D., Gidlund, M., & Corbett, C. E. P. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00157.x · Cited by 26

Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters

Baharia, R. K., Tandon, R., Sahasrabuddhe, A. A., Sundar, S., & Dube, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097911 · Cited by 26

Production of tumour necrosis factor during murine cutaneous leishmaniasis

Moll, H., BINÖDER, K., Bogdan, C., Solbach, W., & Röllinghoff, M. (1990) · Parasite Immunology · doi:10.1111/j.1365-3024.1990.tb00983.x · Cited by 26

Humoral immunity in leishmaniasis – Prevention or promotion of parasite growth?

Gonçalves, R., Christensen, S. M., & Mosser, D. M. (2020) · Cytokine X · doi:10.1016/j.cytox.2020.100046 · Cited by 24

Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity

Frosch, S., Küntzlin, D., & Fleischer, B. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.971-977.1997 · Cited by 23

Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos

Asthana, S., Gupta, P. K., Chaurasia, M., Dube, A., & Chourasia, M. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.838216 · Cited by 22

IL-12Rβ2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response

Chakir, H., Campos‐Neto, A., Mojibian, M., & Webb, J. R. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00024-8 · Cited by 22

Biogenesis of Leishmania major -Harboring Vacuoles in Murine Dendritic Cells

Körner, U., Fuss, V., Steigerwald, J., & Moll, H. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1305-1312.2006 · Cited by 22

Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice

Masic, A., Valencia‐Hernandez, A. M., Hazra, S. K., Glaser, J., Holzgrabe, U., Hazra, B., & Schurigt, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142386 · Cited by 21

Natural killer cells in cross-regulation of IL-12 by IL-10 inLeishmaniaantigen-stimulated blood donor cells

Akuffo, H., Alexis, A., Eidsmo, L., Саед, А. А., Nylén, S., & Maasho, K. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00994.x · Cited by 21

Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis

Skeiky, Y. A. W., Benson, D. R., Costa, J. L., Badaró, R. J. D. S., & Reed, S. G. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5368-5370.1997 · Cited by 21

Increased Interleukin 4 (IL-4) Receptor Expression and IL-4-Induced Decrease in IL-12 Production by Langerhans Cells Infected withLeishmania major

Moll, H., Scharner, A., & Kämpgen, E. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1627-1630.2002 · Cited by 21

Susceptibility to Leishmania major in IL‐4 transgenic mice is not correlated with the lack of a Th1 immune response

Erb, K. J., Blank, C., & Moll, H. (1996) · Immunology and Cell Biology · doi:10.1038/icb.1996.43 · Cited by 20

Antigen-specific multifunctional T-cells in sarcoidosis patients with Löfgren’s syndrome

Wikén, M., Ostadkarampour, M., Eklúnd, A., Willett, M. H., Chen, E., Möller, D. R., Grünewald, J., & Wahlström, J. (2011) · European Respiratory Journal · doi:10.1183/09031936.00166110 · Cited by 19

Granuloma formation in leishmaniasis: A mathematical model

Siewe, N., Yakubu, A., Satoskar, A. R., & Friedman, A. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.10.004 · Cited by 19

Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages

Arens, K., Filippis, C., Kleinfelder, H., Goetzee, A. G., Reichmann, G., Crauwels, P., Waibler, Z., Bagola, K., & van Zandbergen, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01772 · Cited by 19

Leishmania (L). amazonensis induces hyperalgesia in balb/c mice: Contribution of endogenous spinal cord TNFα and NFκB activation

Borghi, S. M., Fattori, V., Ruiz-Miyazawa, K. W., Miranda-Sapla, M. M., Casagrande, R., Pinge‐Filho, P., Pavanelli, W. R., & Verri, W. A., Jr. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.02.009 · Cited by 18

Dendritic Cell-Mediated Vaccination Relies on Interleukin-4 Receptor Signaling to Avoid Tissue Damage after Leishmania major Infection of BALB/c Mice

Masic, A., Hurdayal, R., Nieuwenhuizen, N. E., Brombacher, F., & Moll, H. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001721 · Cited by 18

In situ immune responses to interstitial pneumonitis in human visceral leishmaniasis

Tuon, F. F., Guedes, F., Fernandes, E. R., Pagliari, C., Amato, V. S., & Duarte, M. I. S. (2008) · Parasite Immunology · doi:10.1111/j.1365-3024.2008.01080.x · Cited by 18

Immunization with Apical Membrane Antigen 1 Confers Sterile Infection-Blocking Immunity against Plasmodium Sporozoite Challenge in a Rodent Model

Schussek, S., Trieu, A., Apte, S. H., Sidney, J., Sette, A., & Doolan, D. L. (2013) · Infection and Immunity · doi:10.1128/iai.00544-13 · Cited by 18

TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice

Wilhelm, P., Wiede, F., Meißner, A., Donhauser, N., Bogdan, C., & Körner, H. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.05.005 · Cited by 18

Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis

Masih, S., Arora, S. K., & Vasishta, R. K. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.05.014 · Cited by 17

Acute IL-4 Governs Pathogenic T Cell Responses during Leishmania major Infection

Poudel, B., Yorek, M. S., Mazgaeen, L., Brown, S. A., Kanneganti, T., & Gurung, P. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000076 · Cited by 16

Enhanced protective efficacy against M ycobacterium tuberculosis afforded by BCG prime‐ DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin‐2‐producing CD 4 T‐cell frequency post‐vaccination

Kang, H., Yuan, Q., Ma, H., Hu, Z., Han, D., Wu, K., Lowrie, D. B., & Fan, X. (2014) · Immunology · doi:10.1111/imm.12348 · Cited by 15

Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection

Schleicher, U., Liese, J., Justies, N., Mischke, T., Haeberlein, S., Sebald, H., Kalinke, U., Weiß, S., & Bogdan, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00079 · Cited by 15

Efficient synthesis of (R)-harmonine – the toxic principle of the multicolored Asian lady beetle (Harmonia axyridis)

Nagel, N., Masic, A., Schurigt, U., & Boland, W. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00461f · Cited by 15

4.2 The Leishmaniasis Model

Kropf, P., Müller, I., Brunson, K., & Etges, R. (1998) · Methods in microbiology · doi:10.1016/s0580-9517(08)70688-3 · Cited by 15

Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection

Laskay, T., Mariam, H. G., Berhane, T. Y., Fehniger, T. E., & Kiessling, R. W. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.4.757-763.1991 · Cited by 15

Generation of Cytokines in Human Visceral Leishmaniasis: Dissociation of Endogenous TNF-α and IL-1β Production

Zwingenberger, K., Harms, G., Pedrosa, C. M. S., Pessoa, M. C., Sandkamp, B., Scheibenbogen, C., & Andreesen, R. (1991) · Immunobiology · doi:10.1016/s0171-2985(11)80192-0 · Cited by 13

Cellular therapy by allogeneic macrophages against visceral leishmaniasis: Role of TNF-α

Manna, P. P., Hira, S. K., Basu, A., & Bandyopadhyay, S. K. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.06.001 · Cited by 11

Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).

Khan, M. A. K., Maruno, M., Khaskhely, N. M., Ramzi, S. T., Hosokawa, A., Uezato, H., Landires, E. A. G., Hashiguchi, Y., & Nonaka, S. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.67.184 · Cited by 11

Comparison of Lethal and Nonlethal Mouse Models of Orientia tsutsugamushi Infection Reveals T-Cell Population-Associated Cytokine Signatures Correlated with Lethality and Protection

Luce-Fedrow, A., Chattopadhyay, S., Chan, T., Pearson, G., Patton, J. B., & Richards, A. L. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6030121 · Cited by 11

Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines

Arora, S. K., Pal, N. S., & Mujtaba, S. (2005) · Experimental Parasitology · doi:10.1016/j.exppara.2004.12.009 · Cited by 11

Aryl Hydrocarbon Receptor-Signaling Regulates Early Leishmania major-Induced Cytokine Expression

Münck, N., Roth, J., Sunderkötter, C. H., & Ehrchen, J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02442 · Cited by 10

CASE REPORT: A patient who developed an amoebic liver abscess during treatment with interferon

MATSUO, T., Shinzawa, H., Sugahara, K., MITSUHASHI, H., Watanabe, H., ABE, T., Ohno, S., Terashita, M., Saito, K., Saito, T., et al. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00572.x · Cited by 10

NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells

Kohlhapp, F. J., O’Sullivan, J. A., Moore, T. V., Zloza, A., & Guevara-Patino, J. A. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2022.12.013 · Cited by 9

Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis

Singh, N., & Sundar, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199817 · Cited by 9

Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG

Stefani, M. M. A., Müller, I., & Louis, J. A. (1993) · Research in Immunology · doi:10.1016/0923-2494(93)80100-d · Cited by 9

Mechanisms of resistance to Leishmania aethiopica. I. Interferon‐γ in combination with a cytokine (not tumor necrosis factor‐α) is required, but cannot act alone in the inhibition of intracellular forms of L. aethiopica in THP1 cells

Mohamed, A. M., Taye, T., & Akuffo, H. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220923 · Cited by 9

Immunogenicity of Potential CD4+ and CD8+ T Cell Epitopes Derived From the Proteome of Leishmania braziliensis

Silva, R. D. F. E., de Oliveira, B. C., da Silva, A. A., de Castro, M. C. A. B., Ferreira, L. F., Hernandes, M. Z., de Brito, M. E. F., Neto, O. P. D. M., Rezende, A. M., & Pereira, V. R. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03145 · Cited by 8

Experimental leishmaniasis: synergistic effect of ion channel blockers and interferon-γ on the clearance of Leishmania major by macrophages

Ponte‐Sucre, A., Mendoza-León, A., & Moll, H. (2001) · Parasitology Research · doi:10.1007/s004360000290 · Cited by 8

Primary and memory immune responses against rough Brucella canis are less robust compared to smooth B. abortus and B. melitensis following intratracheal infection in mice

Stranahan, L. W., Garcia-Gonzalez, D. G., Hensel, M. E., & Arenas-Gamboa, Á. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959328 · Cited by 7

Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis

Govender, M., Hurdayal, R., Martínez-Salazar, B., Gqada, K., Pillay, S., Gcanga, L., Passelli, K., Nieuwenhuizen, N. E., Tacchini‐Cottier, F., Guler, R., et al. (2018) · Infection and Immunity · doi:10.1128/iai.00710-18 · Cited by 7

Nitric Oxide in Leishmaniasis

Bogdan, C., Röllinghoff, M., & Diefenbach, A. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46816-6_17 · Cited by 7

Differential inflammatory responses associated with Leishmania major and L tropica in culture

Darzi, F., Davoudian, R., & Rostami, M. N. (2021) · Parasite Immunology · doi:10.1111/pim.12841 · Cited by 6

Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis

Agallou, M., Margaroni, M., & Karagouni, E. (2023) · Vaccines · doi:10.3390/vaccines11081384 · Cited by 6

Recombinant LPG3 Stimulates IFN-Γ and TNF-A Secretion by Human NK Cells.

Rasolzadeh, S., Haji-Fatahaliha, M., Hosseini, M., Jafari, R., Miahipour, A., Sadreddini, S., Babalo, Z., Kafil, H. S., & Yousefi, M. (2015) · PubMed Central · Cited by 6

An amphotericin B-based drug for treating experimental Leishmania major infection

Corware, K., Rogers, M. E., Teo, I. A., Müller, I., & Shaunak, S. (2010) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2010.08.010 · Cited by 5

Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge

Sainz-Mejías, M., Ma, C., Hou, Y., Jurado‐Martín, I., Romerio, A., Franco, A. R., Shaik, M. M., Tomás‐Cortázar, J., Peri, F., & McClean, S. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00932 · Cited by 4

Leishmania donovani Induces Multiple Dynamic Responses in the Metabolome Associated with Amastigote Differentiation and Maturation Inside the Human Macrophage

Fernández-García, M., Mesquita, I., Ferreira, C., Araújo, M., Saha, B., Rey-Stolle, F., Garcı́a, A., Silvestre, R., & Barbas, C. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00845 · Cited by 4

In vitro and in vivo evaluation of quinones from Auxemma oncocalyx Taub. on Leishmania braziliensis

Sayonara, D. M. V., Maria, A. D. F., Guerra, P. V., Glauce, S. B. V., & Maria, J. T. (2015) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2014.5141 · Cited by 4

Regulation of macrophage functions by macrophage deactivating factor, a tumor cell-derived cytokine

Bogdan, C., Yoram Vodovotz, B., & Nathan, C. F. (1992) · Springer eBooks · doi:10.1007/978-94-015-8070-0_51 · Cited by 4

Macrophage activation by recombinant cytokines

Langermans, J. A. M., Nibbering, P. H., van der Hulst, M. E. B., & van Furth, R. (1992) · Springer eBooks · doi:10.1007/978-94-015-8070-0_80 · Cited by 3

Immunogenicity of a recombinant vaccine against Lawsonia intracellularis in mice

Conrad, N. L., Zorzi, V. S. G., Mazzoleni, I., Costa, A. V., Piraine, R. E. A., & Leite, F. P. L. (2025) · Veterinary Vaccine · doi:10.1016/j.vetvac.2025.100132 · Cited by 2

The Role of the Immune System in Resistance to Infection

Kedzierski, Ł., & Evans, K. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-74186-4_5 · Cited by 2

The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model

Livne, A., Youngster, I., El-On, Y., Berkovitch, M., & Abu‐Kishk, I. (2015) · Acta Parasitologica · doi:10.1515/ap-2015-0048 · Cited by 2

The growth and infectivity of Leishmania major is not altered by in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

Sazhnev, V., & DeKrey, G. K. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3759-x · Cited by 2

Reassessing Twenty Years of Vaccine Development Against Tuberculosis

Schaible, U. E., & Kaufmann, S. H. E. (2018) · Frontiers research topics · doi:10.3389/978-2-88945-446-4 · Cited by 2

Immunoinformatic Analysis of Leishmania Major gp46 Protein and Potential Targets for Vaccination against Leishmaniasis

Ahmadi, M. R. H., Mamizadeh, M., Siamian, D., Touyeh, M. A. A., Shams, M., & Rashidi, Y. (2024) · Recent Advances in Inflammation & Allergy Drug Discovery · doi:10.2174/0127722708283588240124095057 · Cited by 1

Mevalonate kinase of Leishmania donovani promotes its survival and plays a pivotal role in pathogenesis

Shafi, T., Bamra, T., Roy, C., Kumar, M., & Das, P. K. (2024) · Experimental Parasitology · doi:10.1016/j.exppara.2024.108800 · Cited by 1

Effects of Migonemyia migonei salivary gland homogenates on Leishmania (Viannia) braziliensis infection in BALB/c mice

Miranda, D. E. D. O., Sales, K. G. D. S., Figueredo, L. A., de Oliveira, S. A., do Nascimento, A. V., Torres, D. J. L., Sumová, P., Volf, P., Brandão-Filho, S. P., de Albuquerque, S. D. C. G., et al. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2021.106271 · Cited by 1

Manifestações clínicas, laboratoriais e a função dos fagócitos em crianças com leishmaniose visceral tratadas com glucantime

Cardoso, V. V. (2007) · Americanae (AECID Library)

Functional competence of CD8+ T cell responses specific to human cytomegalovirus in common variable immunodeficiency

Marashi, S. M. (2011) · UCL Discovery (University College London)

Lung T cells in inflammatory disorders : an approach to interstitial lung disease, multiple sclerosis and smoking induced inflammation

Ostadkarampour, M. (2014) · Figshare

Can Attenuated Leishmania Induce Equally Effective Protection as Virulent Strains in Visceral Leishmaniasis?

Cunha, J., Carrillo, E., Moreno, J., & Cordeiro‐da‐Silva, A. (2014) · InTech eBooks · doi:10.5772/57214

Generation of polyfunctional T cells against HCV by T cell redirection and vaccination

Pasetto, A. (2012) · Figshare

Innate and Adaptive Immune Responses in Pulmonary Sarcoidosis

Wikén, M. (2010) · Figshare

Intranasal Vaccination with Murine Cytomegalovirus Expressing Respiratory Syncytial Virus Antigens Promotes Tissue-resident Memory CD8+ T cells

Morabito, K. M. (2015) · ProQuest Demo Repository

Charakterisierung der neutrophilen Granulozyten von suszeptiblen BALB/c- und resistenten C57BL/6-Mäusen im experimentellen Modell der Leishmaniasis

Fakultät, M. (2011)

The Inflammatory Process

Kovacs, E. J., & Frazier-Jessen, M. R. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-628930-5.50007-2

Enhanced tumor-specific immunity of oncolytic adenovirus co-expressing IL-12 and IL-23

최일규 (2012) · YUHSpace (Yonsei University Medical Library)

Dendritic cells activated by CpG motifs are potent inducers of a Th1 immune response that protects mice against leishmaniasis

Ramírez, P., & Robinson, J. (2003)

The Role of the Immune System in Resistance to Infection

Kedzierski, Ł., & Evans, K. J. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1125-3_5

Immunopathologie des infections Plasmodium chabaudi virulentes et non virulentes dans les souris C57BL/6

Tshitenge, T. C. (2012) · theses.fr (ABES) · doi:10.70675/8b15960dzcd0fz429ezb482zd7450842fb88

Rôle de la protéine Pleckstrin dans la génération de lymphocytes T CD8 mémoires et la mise en place d'une immunité tissulaire

Calvez, M. (2018) · theses.fr (ABES) · doi:10.70675/12363b3fz08c5z4f59zbb0bz16e5b97d5a12

Leishmania infantum extracellular material and human invariant natural killer T cells : a functional study

Belo, R. (2017) · theses.fr (ABES) · doi:10.70675/e0088998ze080z4d35zbfe5z385f1b3b82d0

Strategy of researches on marine bivalve defense mechanisms

Evelyne Bachère, B., Mialhe, E., Noël, T., Boulo, V., Hervio‐Heath, D., Gall, G. L., & Morvan, A. (1991) · Institutional Archive of Ifremer (French Research Institute for Exploitation of the Sea)

Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor‐α production by macrophages is induced by the synergistic action of interferon (IFN)‐γ and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN‐γ and IL 4

Stenger, S., Solbach, W., Röllinghoff, M., & Bogdan, C. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210713 · Cited by 55

Tumor necrosis factor- alpha synergizes with IFN- gamma in mediating killing of Leishmania major through the induction of nitric oxide.

Liew, F. Y., Li, Y., & Millott, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4306 · Cited by 522

Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo

Theodos, C. M., Povinelli, L., Molina, R., Sherry, B. A., & Titus, R. G. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2839-2842.1991 · Cited by 66

Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon‐γ to activate murine macrophages for killing of Leishmania major amastigotes

Bogdan, C., Stenger, S., Röllinghoff, M., & Solbach, W. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210213 · Cited by 79

Leishmania major: leishmanicidal activity of activated macrophages by interferon gamma or tumour necrosis factor.

Na, H., Negm, A. Y., Hussein, E. D., El-Temsahy, M. M., & Ea, R. (1996) · PubMed · Cited by 3